Adamant Biomedical Investments AG

Entity
Company
Business address
Freischuetzgasse 3, 8004 Zurich, Switzerland
Phone
41-61-275-9200
State of incorporation
Switzerland
Fiscal year end
December 31
Signature 13F
Dr. Cyrill Zimmerman - CEO
All SEC filings
View on sec.gov
Adamant Biomedical Investments AG has filed 14 SEC EDGAR filings since 2/14/2012

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
13F-HR Open Document Open Filing Feb 13, 2015 Dec 31, 2014 028-14829
SC 13G Open Document Open Filing SCHEDULE 13G Feb 13, 2015
13F-HR Open Document Open Filing Nov 14, 2014 Sep 30, 2014 028-14829
13F-NT Open Document Open Filing Aug 7, 2014 Jun 30, 2014 028-14829
13F-NT Open Document Open Filing Apr 29, 2014 Mar 31, 2014 028-14829
13F-NT Open Document Open Filing Feb 3, 2014 Dec 31, 2013 028-14829